Peroxisomal very long chain fatty acid β-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression

Molecular Genetics and Metabolism

Volumn 66, Issue 2, 1999, Pages 91-99

  Braiterman, Lelita T ^a,b   Watkins, Paul A ^a,b   Moser, Ann B ^a   Smith, Kirby D ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALDP; Peroxisome SV40T antigen transformation; X linked adrenoleukodystrophy; oxidation

Indexed keywords

ACYL COENZYME A OXIDASE; LIGNOCERIC ACID; PALMITIC ACID; PHYTANIC ACID; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; X CHROMOSOME LINKED DISORDER;

EID: 0032776070     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2789     Document Type: Article

References (47)

1. Zellweger H. The cerebro-hepato-renal (Zellweger) syndrome and other peroxisomal disorders. Dev Med Child Neurol. 29:1987;821-829.
2. Moser H W, Smith K D, Moser A B. X-linked adrenoleukodystrophy. In The Metabolic and Molecular Bases of Inherited Disease. 1995;McGraw-Hill, New York. p. 2325-2349.
3. Poll-The B T, Roels F, Ogier H, Scotto J, Vamecq J, Schutgens R B, Wanders R JA. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet. 42:1988;422-438.
4. Watkins P A, Chen W W, Harris C J, Hoefler G, Blake J DC, Balfe A, Kelley R. Peroxisomal bifunctional enzyme deficiency. J Clin Invest. 83:1988;771-777.
5. Schram A, Goldfischer S, van Roermund C T, Brouwer-Kelder E M, Collins J, Hashimoto T, Heymans H SA. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA. 84:1987;2494-2496.
6. Osumi T. Structure and expression of the genes encoding peroxisomal beta-oxidation enzymes. Biochimie. 75:1993;243-250.
7. Hashimoto T. Purification, properties and biosynthesis of peroxisomal beta-oxidation enzymes. Fatty Acid Oxidation. 321:1990;137-152.
8. Aoyama T, Souri M, Kamijo T, Ushikubo S, Hashimoto T. Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid β-oxidation system. Biochem Biophys Res Commun. 201:1994;1541-1547.
9. Mosser J, Douar A-M, Sarde C-O, Kioschis P, Feil R, Moser H, Poustka A-M. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:1993;726-730.
10. Uchiyama A, Aoyama T, Kamijo K, Uchida Y, Kondo M, Orii T. Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J Biol Chem. 271:1996;30360-30365.
11. Poulos A, Singh H, Paton B, Sharp P, Derwas N. Accumulation and defective β-oxidation of very long-chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants. Clin Genet. 29:1986;397-408.
12. Smith K D, Kemp S, Braiterman L T, Lu J-F, Wei H-M, Stetten G, Bergin J S. X-linked adrenoleukodystrophy: genes, mutations and phenotypes. Neruochem Res. 24:1998;511-525.
13. Wanders R JA, van Roermund C WT, van Wijland M JA, Schutgens R BH, van den Bosch H, Schram A W, Tager J M. Direct evidence that the deficient oxidation of very long-chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long-chain fatty acids. Biochem Biophys Res Commun. 153:1988;618-624.
14. Lazo O, Contreras M, Bhushan A, Stanley W, Singh I. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biophys. 270:1989;722-728.
15. Watkins P A, Gould S J, Smith M A, Braiterman L T, Wei H-M, Kok F, Moser A B. Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet. 57:1995;292-301.
16. McGuinness M C, Moser A B, Poll-the B T, Watkins P A. Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation. Biochem Med Metab Biol. 49:1993;228-242.
17. Dodt G, Braverman N, Wong C, Moser A, Moser H W, Watkins P, Valle D. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nature Genet. 9:1995;115-125.
18. Watkins P A, Ferrell E V, Pedersen J I, Hoefler G. Peroxisomal fatty acid β-oxidation in HepG2 cells. Arch Biochem Biophys. 289:1991;329-336.
19. Mihalik S J, Soliman T M, Day R F, Watkins P A. Involvement of both peroxisomes and mitochondria in the alpha-oxidation of phytanic acid. Prog Clin Biol Res. 375:1992;239-244.
20. Moser, H, W, Moser, A, B, Measurement of saturated very long-chain fatty acids in plasma, Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manuel, Hommes, F, E, New York, Wiley-Liss, 177, 191, 1991.
21. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
22. Furuta S, Hayashi H, Hijikata M, Miyazawa S, Osumi T, Hashimoto T. Complete nucleotide sequence of rat liver catalase. Proc Natl Acad Sci USA. 83:1986;313-317.
23. Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem. 265:1990;4534-4540.
24. Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland M-O, Jorge P, Mosser J. Retroviral-mediated gene transfer corrects very long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci USA. 92:1995;1674-1678.
25. Shinnoh N, Yamada T, Yoshimura T, Furuya H, Yoshida Y, Suzuki Y, Shimozawa N. Adrenoleukodystrophy: The restoration of peroxisomal β-oxidation by transfection of normal cDNA. Biochem Biophys Res Commun. 210:1995;830-836.
26. Braiterman L T, Zheng S, Watkins P A, Geraghty M T, Johnson G, McGuiness M C, Moser A B. Suppression of peroxisomal membrane protein defects by peroxisomal ATP-binding cassette (ABC) proteins. Hum Mol Genet. 7:1998;239-247.
27. Braiterman L T, Zheng S, Watkins P A, Johnson G, Moser A B, Moser H W, Smith K D. Functional studies of the X-linked adrenoleukodystrophy protein. Ann N Y Acad Sci. 84:1996;763-764.
28. Endresen M J. The role of fatty acids in gene regulation: an example of an important nutritional factor which may influence our genes. Tidsskr Nor Laegeforen. 115:1995;2084-2086.
29. Schmidt A, Vogel R L, Witherup K M, Rutledge S J, Pitzenberger M, Adam M, Rodan G A. Identification of fatty acid methyl esters as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family. Lipids. 31:1996;1115-1124.
30. Neat C E, Thomassen M S, Osmundsen H. Induction of peroxisomal beta-oxidation in rat liver by high-fat diets. Biochem J. 186:1980;369-371.
31. Ide T, Murata M, Sugano M. Stimulation of the activities of the hepatic fatty acid oxidation enzymes by dietary fat rich in alpha-linolenic acid in rats. J Lipid Res. 37:1996;448-463.
32. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the Peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
33. Krey G, Mahfoudi A, Wahli W. Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor and Sp1 in the transcriptional regulation of the acyl-coenzyme-A oxidase promoter. Mol Endocrinol. 9:1995;219-231.
34. Varanasi U, Chu R, Chu S, Espinsoa R, LeBeau M M, Reddy J K. Isolation of the human peroxisomal acyl-CoA oxidase gene: organization, promoter analysis and chromosomal localization. Proc Natl Acad Sci USA. 91:1994;3107-3111.
35. Vuillaume M, Calvayrac R, Best-Belpomme M, Tarroux P, Hubert M, Decroix Y, Sarasun A. Deficiency in the catalase activity of xeroderma pigmentosum cell and simian virus 40-transformed human cell extracts. Cancer Res. 46:1986;538-544.
36. Keller J-M, Cable S, El Bouhtoury F, Heusser S, Scotto C, Armbruster L, Ciolek E, Schilt J, Dauca M. Peroxisome through cell differentiation and neoplasia. Biol Cell. 77:1993;77-88.
37. Jat P S. Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts. J Virol. 59:1986;746-750.
38. Butel J S. SV40 large T-antigen: dual oncogene. Cancer Surv. 5:1986;343-365.
39. Bioukar E B, Sarrazin S, Conti M, Rabetafika E, Carreau J P, Dhorne-Pollet S, Raynaud N. Extinction of peroxisomal functions in hepatoma cell-fibroblast hybrids. Biochem Genet. 34:1996;77-91.
40. Sarde C-O, Mosser J, Kioschis P, Kretz C, Vicaire S, Aubourg P, Poustka A. Genomic organization of the adrenoleukodystrophy gene. Genomics. 22:1994;13-20.
41. Albet S, Causeret C, Bentejac M, Mandel J-L, Auborg P, Maurice B. Fenofibrate differently alters expression of genes encoding ATP-binding transporter proteins of the peroxisomal membrane. FEBS Lett. 405:1997;394-397.
42. Wanders R J, van Roermund C W, van Wijland M J, Schutgens R B, Keikoop J, van den Bosch H W, Schram A W. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long-chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. J Clin Invest. 80:1987;1778-1783.
43. Lombard-Platet G, Savary S, Sarde C O, Mandel J-L, Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc Natl Acad Sci USA. 93:1996;1265-1269.
44. Shani N, Jimenez-Sanchez G, Steel G, Dean M, Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. Hum Mol Genet. 6:1997;1925-1931.
45. Holzinger A, Kammerer S, Berger J, Roscher A A. cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter. Biochem Biophys Res Commun. 239:1997;261-264.
46. Kemp S, Wei H-M, Lu J-F, Braiterman L T, McGuinness M, Watkins P A, Moser A B. Gene redundancy and pharmacological gene therapy: potential for X-linked adrenoleukodystrophy. Nat Med. 4:1998;1261-1268.
47. Tanaka Y, Ando S, Tsuji S, Miyatake T. Enhanced synthesis of hexacosanoic acid in the cultured fibroblasts from patients with adrenoleukodystrophy. Biomed Res. 9:1988;451-456.